<scp>FMOD</scp> expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot studyMarc Sorigué, Lurdes Zamora, Gustavo Tapia et al.|Cytometry Part B Clinical Cytometry|2020Cited by 15
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemiaRebeca Jurado Tapiador, Marc Sorigué, María Luisa López Huguet et al.|Cytometry Part B Clinical Cytometry|2022Cited by 12
Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitorsSílvia Marcé, Fuensanta Millá, Lurdes Zamora et al.|Medicina Clínica|2013Cited by 11
Chronic myelomonocytic leukemia and blastic plasmacytoid dendritic cell neoplasm. A case report and systematic reviewAndrea Espasa, Blanca Xicoy, Marc Sorigué et al.|Cytometry Part B Clinical Cytometry|2020Cited by 8
Flow cytometry to detect bone marrow involvement by follicular lymphomaMercè Aren, Marc Sorigué, Sílvia Marcé et al.|Cytometry Part B Clinical Cytometry|2022Cited by 5